Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Chinese Patent Office
Daiichi Sankyo
UBS
Fish and Richardson
AstraZeneca
Fuji
Cantor Fitzgerald

Generated: April 26, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: caspofungin acetate

« Back to Dashboard

caspofungin acetate Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Sandoz Inc caspofungin acetate 200833 70MG/VIAL INJECTABLE; INJECTION
Sandoz Inc caspofungin acetate 200833 50MG/VIAL INJECTABLE; INJECTION
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Baxter
Cantor Fitzgerald
Harvard Business School
AstraZeneca
Chinese Patent Office
Merck
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.